ENOV
Enovis Corporation NYSE Listed May 8, 2008$27.27
Mkt Cap $1.6B
52w Low $21.00
37.2% of range
52w High $37.85
50d MA $23.81
200d MA $27.12
P/E (TTM)
-1.1x
EV/EBITDA
-3.4x
P/B
0.9x
Debt/Equity
0.9x
ROE
-79.5%
P/FCF
76.0x
RSI (14)
—
ATR (14)
—
Beta
1.59
50d MA
$23.81
200d MA
$27.12
Avg Volume
989.5K
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
2711 Centerville Road · Wilmington, DE 19808 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 24.85 | +1.2% | +9.7% | -2.7% | — | — | — | — |
| Feb 26, 2026 | AMC | 0.81 | 0.95 | +17.3% | 25.42 | +0.3% | +0.2% | +0.9% | -1.6% | +2.0% | -5.7% | — |
| Nov 6, 2025 | AMC | 0.67 | 0.75 | +11.9% | 28.42 | -1.7% | -1.3% | +7.8% | +4.1% | -0.9% | -1.2% | — |
| Aug 7, 2025 | AMC | 0.74 | 0.79 | +6.8% | 28.52 | +0.0% | -0.3% | -1.2% | +2.3% | +2.9% | -2.6% | — |
| May 8, 2025 | AMC | 0.74 | 0.81 | +9.5% | 33.08 | -1.1% | -0.1% | +10.7% | +2.1% | -3.0% | -1.4% | — |
| Feb 26, 2025 | AMC | 0.92 | 0.98 | +6.5% | 40.00 | -0.3% | -4.7% | +1.4% | -2.0% | -3.3% | +2.7% | — |
| Nov 6, 2024 | AMC | 0.63 | 0.73 | +15.9% | 46.90 | -1.2% | +2.0% | -3.0% | +2.0% | -0.9% | -1.0% | — |
| Aug 7, 2024 | AMC | 0.60 | 0.62 | +3.3% | 40.57 | +2.4% | +7.4% | -0.4% | -2.3% | +2.1% | -0.6% | — |
| May 2, 2024 | AMC | 0.50 | 0.50 | +0.0% | 52.13 | +0.5% | -1.6% | -0.7% | +2.6% | -3.0% | +0.8% | — |
| Feb 22, 2024 | AMC | 0.76 | 0.79 | +3.9% | 63.80 | -0.7% | -1.5% | -2.1% | -0.2% | -1.1% | -1.6% | — |
| Nov 7, 2023 | AMC | 0.53 | 0.56 | +5.7% | 48.33 | +0.4% | -0.2% | -1.9% | +1.1% | +0.7% | +4.2% | — |
| Aug 3, 2023 | AMC | 0.53 | 0.61 | +15.1% | 58.96 | +1.6% | +0.5% | -0.3% | -2.2% | -2.0% | -1.3% | — |
| May 4, 2023 | AMC | 0.37 | 0.44 | +18.9% | 57.54 | +1.1% | -0.2% | -0.9% | -1.0% | -0.6% | -0.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $22.64 | $22.33 | -1.4% | +0.5% | -1.1% | +5.6% | +0.9% | +1.8% |
| Feb 26 | BTIG | Maintains | Buy → Buy | — | $22.32 | $22.62 | +1.3% | +13.9% | +0.2% | +0.9% | -1.6% | +2.0% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $22.32 | $22.62 | +1.3% | +13.9% | +0.2% | +0.9% | -1.6% | +2.0% |
| Dec 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $26.07 | $26.63 | +2.1% | +4.9% | -0.1% | -2.0% | +1.6% | -3.3% |
| Nov 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.42 | $27.95 | -1.7% | -1.3% | +7.8% | +4.1% | -0.9% | -1.2% |
| Aug 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.52 | $28.53 | +0.0% | -0.3% | -1.2% | +2.3% | +2.9% | -2.6% |
| Aug 8 | UBS | Maintains | Buy → Buy | — | $28.52 | $28.53 | +0.0% | -0.3% | -1.2% | +2.3% | +2.9% | -2.6% |
| Aug 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $28.52 | $28.53 | +0.0% | -0.3% | -1.2% | +2.3% | +2.9% | -2.6% |
| Aug 7 | Needham | Maintains | Buy → Buy | — | $25.76 | $27.58 | +7.1% | +10.7% | -0.3% | -1.2% | +2.3% | +2.9% |
| Jul 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $33.02 | $33.30 | +0.8% | +5.2% | +2.4% | +1.1% | -5.3% | -6.1% |
| May 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $37.35 | $37.05 | -0.8% | -3.0% | -1.4% | +0.9% | -1.6% | -2.8% |
| May 9 | Needham | Maintains | Buy → Buy | — | $33.08 | $32.72 | -1.1% | -0.1% | +10.7% | +2.1% | -3.0% | -1.4% |
| May 9 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $33.08 | $32.72 | -1.1% | -0.1% | +10.7% | +2.1% | -3.0% | -1.4% |
| Apr 9 | Needham | Maintains | Buy → Buy | — | $30.66 | $30.00 | -2.2% | +11.6% | -6.2% | -0.3% | +0.9% | -2.6% |
| Apr 2 | Needham | Maintains | Buy → Buy | — | $37.18 | $35.81 | -3.7% | -0.5% | -8.6% | -3.7% | -0.1% | -5.7% |
| Feb 27 | Needham | Maintains | Buy → Buy | — | $40.00 | $39.88 | -0.3% | -4.7% | +1.4% | -2.0% | -3.3% | +2.7% |
| Nov 7 | Needham | Maintains | Buy → Buy | — | $46.90 | $46.34 | -1.2% | +2.0% | -3.0% | +2.0% | -0.9% | -1.0% |
| Oct 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $43.05 | $42.75 | -0.7% | -3.7% | -1.5% | -2.2% | +1.8% | -2.6% |
| Aug 8 | JP Morgan | Maintains | Neutral → Neutral | — | $40.57 | $41.54 | +2.4% | +7.4% | -0.4% | -2.3% | +2.1% | -0.6% |
| Aug 8 | Needham | Maintains | Buy → Buy | — | $40.57 | $41.54 | +2.4% | +7.4% | -0.4% | -2.3% | +2.1% | -0.6% |
| Jul 2 | Evercore ISI | Maintains | Outperform → Outperform | — | $44.35 | $44.35 | +0.0% | +0.8% | -0.6% | +0.9% | -1.0% | -1.4% |
| May 3 | Needham | Maintains | Buy → Buy | — | $52.13 | $52.37 | +0.5% | -1.6% | -0.7% | +2.6% | -3.0% | +0.8% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $62.43 | $61.79 | -1.0% | -4.0% | -0.3% | -2.1% | -3.0% | -0.5% |
| Feb 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $63.80 | $63.38 | -0.7% | -1.5% | -2.1% | -0.2% | -1.1% | -1.6% |
| Feb 23 | Needham | Maintains | Buy → Buy | — | $63.80 | $63.38 | -0.7% | -1.5% | -2.1% | -0.2% | -1.1% | -1.6% |
| Feb 23 | Canaccord Genuity | Maintains | Buy → Buy | — | $63.80 | $63.38 | -0.7% | -1.5% | -2.1% | -0.2% | -1.1% | -1.6% |
| Jan 8 | Needham | Maintains | Buy → Buy | — | $56.21 | $56.88 | +1.2% | +2.0% | +1.1% | +0.8% | -0.5% | -0.4% |
| Dec 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $55.45 | $55.90 | +0.8% | -0.9% | +2.9% | +0.9% | -0.4% | -0.4% |
| Dec 15 | Needham | Maintains | Buy → Buy | — | $53.70 | $54.34 | +1.2% | -0.1% | +0.8% | +2.6% | -0.9% | +2.9% |
| Nov 8 | Needham | Maintains | Buy → Buy | — | $48.33 | $48.52 | +0.4% | -0.2% | -1.9% | +1.1% | +0.7% | +4.2% |
| Oct 20 | Needham | Maintains | Buy → Buy | — | $44.86 | $44.58 | -0.6% | -0.9% | +2.4% | +0.5% | -3.4% | -1.1% |
| Aug 4 | Needham | Maintains | Buy → Buy | — | $58.96 | $59.92 | +1.6% | +0.5% | -0.3% | -2.2% | -2.0% | -1.3% |
| Aug 4 | Baird | Maintains | Outperform → Outperform | — | $58.96 | $59.92 | +1.6% | +0.5% | -0.3% | -2.2% | -2.0% | -1.3% |
| May 12 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $55.79 | $57.17 | +2.5% | +1.3% | +1.3% | -0.9% | -1.7% | -1.3% |
| May 5 | Baird | Maintains | Outperform → Outperform | — | $57.54 | $58.15 | +1.1% | -0.2% | -0.9% | -1.0% | -0.6% | -0.4% |
| Mar 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $50.32 | $49.93 | -0.8% | +0.2% | +3.6% | +1.3% | +1.1% | -0.0% |
| Feb 24 | Baird | Maintains | Outperform → Outperform | — | $57.62 | $56.64 | -1.7% | -3.1% | +2.5% | +0.7% | -0.5% | -0.2% |
| Nov 3 | Baird | Maintains | Outperform → Outperform | — | $47.86 | $46.45 | -2.9% | +6.8% | +1.0% | +3.2% | -1.0% | -1.7% |
| Oct 26 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $48.57 | $48.52 | -0.1% | +2.5% | -1.6% | +2.2% | -1.2% | +0.2% |
| Oct 12 | Jefferies | Maintains | Buy → Buy | — | $44.83 | $45.22 | +0.9% | +0.6% | +2.8% | -2.9% | +5.7% | +0.2% |
| Oct 11 | Goldman Sachs | Maintains | Buy → Buy | — | $44.86 | $45.11 | +0.6% | -0.1% | +0.6% | +2.8% | -2.9% | +5.7% |
| Sep 12 | Evercore ISI | Maintains | Outperform → Outperform | — | $51.55 | $52.41 | +1.7% | +6.0% | -4.9% | +1.6% | -0.3% | -2.5% |
| Sep 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $51.55 | $52.41 | +1.7% | +6.0% | -4.9% | +1.6% | -0.3% | -2.5% |
| Jun 28 | Argus | Maintains | Hold → Hold | — | $58.99 | $58.54 | -0.8% | -4.3% | -1.4% | -1.2% | +1.8% | -0.7% |
| Jun 16 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $61.20 | $59.90 | -2.1% | -6.6% | -1.2% | -1.1% | -1.0% | +0.3% |
| Apr 21 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $70.47 | $70.35 | -0.2% | -3.0% | -1.9% | +0.5% | -1.2% | -2.4% |
No insider trades available.
8-K · 2.02
!! High
Enovis Corporation -- 8-K 2.02: Earnings Results
Enovis reported first-quarter 2026 earnings results on May 7, 2026, providing investors with updated financial performance metrics for the period ending April 3, 2026.
May 7
8-K
Enovis Corporation -- 8-K Filing
Enovis Corporation reported 4% year-over-year growth in Prevention Recovery sales for Q4 2025, demonstrating modest organic expansion in its medical technology segment.
Feb 26
8-K
Middleby Corp -- 8-K Filing
Middleby Corp appointed Christopher Hix to its board of directors, expanding its governance structure with a new board member.
Feb 4
Data updated apr 25, 2026 7:11am
· Source: massive.com